Current therapeutic strategy in bleeding esophageal varices in babies and children and long-term results of endoscopic paravariceal sclerotherapy over twenty years
- PMID: 8086394
- DOI: 10.1055/s-2008-1066093
Current therapeutic strategy in bleeding esophageal varices in babies and children and long-term results of endoscopic paravariceal sclerotherapy over twenty years
Abstract
71 consecutive babies and children with bleeding esophageal varices managed primarily by emergency or elective paravariceal endoscopic sclerotherapy (PES) have been reviewed and followed up for twenty years. In 36 of them 53 different operations to prevent further variceal hemorrhage had been performed without permanent success. In 50 children (70 per cent--Group Ia), portal vein obstruction, in 2 (3 per cent--Group Ib), congenital hepatic fibrosis and in 19 (27 per cent--Group II) babies and children different types of cirrhoses were the cause of portal hypertension. Emergency PES was necessary for 29 and successful for 28 children (96.5 per cent). Recurrent bleeding in one child stopped after introduction and inflation of the Sengstaken-Blakemore tube. In one case an urgent transthoracic esophageal resection and fundoplication was performed because of recurrent hemorrhage in spite of repeated PES. 6 children--3 foreigners--were lost to follow-up after 3, 5, 6, 7, 11 and 12 years. Under regular PES there were 3 rebleedings (4 per cent) during the first month managed successfully by PES or conservatively; another 3 rebleedings (4 per cent) occurred during the first year. In "sclerotherapy failures" (recurrent hemorrhage in spite of chronic PES in 6 children aged more than 10 years 6 elective and selective shunts were carried out 3, 5, 6, 8, 10 and eleven years after the first PES. The number of complications was high, but the vast majority was asymptomatic and no complications was responsible for death. There was no death in children with portal vein obstruction.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
[Emergency sclerotherapy in esophageal varices bleeding: prospective study in unselected patients with portal hypertension].Pol Merkur Lekarski. 2007 May;22(131):354-6. Pol Merkur Lekarski. 2007. PMID: 17679366 Polish.
-
The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices.Hepatogastroenterology. 1995 Nov-Dec;42(6):979-84. Hepatogastroenterology. 1995. PMID: 8847055
-
Esophageal transection versus injection sclerotherapy in the management of bleeding esophageal varices in patients at high risk.Surg Gynecol Obstet. 1985 Jun;160(6):539-46. Surg Gynecol Obstet. 1985. PMID: 3873713 Clinical Trial.
-
[Therapy and prevention of hemorrhage from esophageal varices].Z Gastroenterol. 1990 Jun;28(6):302-14. Z Gastroenterol. 1990. PMID: 2238758 Review. German.
-
[Treatment of hemorrhage of esophageal varices].Leber Magen Darm. 1990 Jan;20(1):11-2, 15-9. Leber Magen Darm. 1990. PMID: 2179657 Review. German.
Cited by
-
Treatment of oesophageal varices.Arch Dis Child. 1997 Dec;77(6):476-7. doi: 10.1136/adc.77.6.476. Arch Dis Child. 1997. PMID: 9496177 Free PMC article. No abstract available.
-
Managing liver failure.Postgrad Med J. 2002 Nov;78(925):660-7. doi: 10.1136/pmj.78.925.660. Postgrad Med J. 2002. PMID: 12496321 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical